Eagle Bay Advisors’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-54
Closed -$4.22K 477
2024
Q4
$4.22K Buy
54
+19
+54% +$1.53K ﹤0.01% 736
2024
Q3
$2.81K Sell
35
-19
-35% -$1.53K ﹤0.01% 1153
2024
Q2
$4.47K Sell
54
-17
-24% -$1.5K ﹤0.01% 738
2024
Q1
$6.06K Sell
71
-26
-27% -$2.04K ﹤0.01% 679
2023
Q4
$8.29K Sell
97
-673
-87% -$58.2K 0.01% 559
2023
Q3
$69K Buy
770
+151
+24% +$13.5K 0.03% 340
2023
Q2
$52.7K Sell
619
-59
-9% -$4.99K 0.03% 354
2023
Q1
$56.1K Sell
678
-114
-14% -$9.23K 0.03% 358
2022
Q4
$62.3K Buy
792
+151
+24% +$12.1K 0.03% 331
2022
Q3
$48K Sell
641
-12
-2% -$862 0.03% 346
2022
Q2
$42.6K Buy
653
+397
+155% +$23.5K 0.03% 401
2022
Q1
$16K Sell
256
-66
-20% -$3.59K 0.01% 242
2021
Q4
$18K Buy
322
+74
+30% +$4.51K 0.01% 583
2021
Q3
$17K Buy
248
+2
+0.8% +$126 0.01% 645
2021
Q2
$18K Buy
+246
New +$17.4K 0.01% 563

Other funds holding HAE